Ellen F. Binder
Washington University in St. Louis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ellen F. Binder.
Journal of the American Geriatrics Society | 2002
Ellen F. Binder; Kenneth B. Schechtman; Ali A. Ehsani; Karen Steger-May; Marybeth Brown; David R. Sinacore; Kevin E. Yarasheski; John O. Holloszy
OBJECTIVES: Although deficits in skeletal muscle strength, gait, balance, and oxygen uptake are potentially reversible causes of frailty, the efficacy of exercise in reversing frailty in community‐dwelling older adults has not been proven. The aim of this study was to determine the effects of intensive exercise training (ET) on measures of physical frailty in older community‐dwelling men and women.
The Journal of Clinical Endocrinology and Metabolism | 2009
Fred R. Sattler; Carmen Castaneda-Sceppa; Ellen F. Binder; E. Todd Schroeder; Ying Wang; Shalender Bhasin; Miwa Kawakubo; Yolanda Stewart; Kevin E. Yarasheski; Jagadish Ulloor; Patrick M. Colletti; Ronenn Roubenoff; Stanley P. Azen
CONTEXT Impairments in the pituitary-gonadal axis with aging are associated with loss of muscle mass and function and accumulation of upper body fat. OBJECTIVES We tested the hypothesis that physiological supplementation with testosterone and GH together improves body composition and muscle performance in older men. DESIGN, SETTING, AND PARTICIPANTS One hundred twenty-two community-dwelling men 70.8 +/- 4.2 yr of age with body mass index of 27.4 +/- 3.4 kg/m2, testosterone of 550 ng/dl or less, and IGF-I in lower adult tertile (< or =167 ng/dl) were randomized to receive transdermal testosterone (5 or 10 g/d) during a Leydig cell clamp plus GH (0, 3, or 5 microg/kg . d) for 16 wk. MAIN OUTCOME MEASURES Body composition by dual-energy x-ray absorptiometry, muscle performance, and safety tests were conducted. RESULTS Total lean body mass increased (1.0 +/- 1.7 to 3.0 +/- 2.2 kg) as did appendicular lean tissue (0.4 +/- 1.4 to 1.5 +/- 1.3 kg), whereas total fat mass decreased by 0.4 +/- 0.9 to 2.3 +/- 1.7 kg as did trunk fat (0.5 +/- 0.9 to 1.5 +/- 1.0 kg) across the six treatment groups and by dose levels for each parameter (P < or = 0.0004 for linear trend). Composite maximum voluntary strength of upper and lower body muscles increased by 14 +/- 34 to 35 +/- 31% (P < 0.003 in the three highest dose groups) that correlated with changes in appendicular lean mass. Aerobic endurance increased in all six groups (average 96 +/- 137 sec longer). Systolic and diastolic blood pressure increased similarly in each group with mean increases of 12 +/- 14 and 8 +/- 8 mm Hg, respectively. Other predictable adverse events were modest and reversible. CONCLUSIONS Supplemental testosterone produced significant gains in total and appendicular lean mass, muscle strength, and aerobic endurance with significant reductions in whole-body and trunk fat. Outcomes appeared to be further enhanced with GH supplementation.
Maturitas | 2001
Ellen F. Binder; Kenneth B. Schechtman; Stanley J. Birge; Daniel B. Williams; Wendy M. Kohrt
OBJECTIVE To determine the effects of 9 months of hormone replacement therapy (HRT) on cognitive performance in women aged 75 years and older. METHODS A 9-month randomized, double-blinded, placebo-controlled parallel trial. Fifty-two elderly postmenopausal women (age range 75-91 years) without known contraindications to HRT or evidence of dementia or depression were enrolled. Participants were randomly assigned in a 1:2 ratio to placebo or conjugated estrogens at 0.625 mg/d plus trimonthly medroxyprogesterone acetate at 5 mg/d for 13 days (HRT). Main outcome measures were change from baseline and rate of change from baseline for the following psychometric tests: Verbal Fluency Test, Weschler Paired Associate Learning and 20 min Delayed Recall, Trailmaking A and B Tests, Cancellation Random Letter and Random Form Tests. RESULTS At baseline, women in the HRT group reported a younger age of onset of menopause and a higher prevalence of hysterectomy, but otherwise did not differ from women in the placebo group. After 9 months of treatment, there were no significant group differences for any of the cognitive performance measures. The lack of an observed group-by-time difference for all cognitive tests remained after controlling for age of onset of menopause, education, and previous hysterectomy. CONCLUSIONS Although conclusions are limited by small sample size and the relatively short duration of treatment, results suggest that 9 months of estrogen replacement in combination with trimonthly progestin does not improve cognitive performance in women over 75 years who do not have dementia or depression.
Journal of the American Geriatrics Society | 1996
Ellen F. Binder; Stanley J. Birge; Wendy M. Kohrt
OBJECTIVE: To determine the effects of 11 months of exercise training and hormone replacement therapy (HRT), alone or in combination, on serum lipids and lipoproteins, in postmenopausal women.
Journal of the American Geriatrics Society | 2003
Dennis T. Villareal; Ellen F. Binder; Kevin E. Yarasheski; Daniel B. Williams; Marybeth Brown; David R. Sinacore; W. M. Kohrt
OBJECTIVES: To determine whether exercise training added to ongoing hormone replacement therapy (HRT) increases bone mineral density (BMD) in physically frail elderly women.
Medical Care | 2004
Robin L. Kruse; David R. Mehr; Boles Ke; Lave; Ellen F. Binder; Richard W. Madsen; Ralph B. D'Agostino
Background:Lower respiratory infection (LRI) is the leading cause of hospitalization for nursing home residents, but hospitalization is costly and may cause complications. Objective:We sought to compare mortality and cost between episodes of LRI initially treated in the hospital versus the nursing home after controlling for illness severity and the probability of hospitalization. Design:This was a prospective cohort study of nursing home residents with LRIs. Subjects:We identified 1406 episodes of LRI in 36 nursing homes in central Missouri and the St. Louis area between August 15, 1995, and September 30, 1998. Economic analysis was restricted to 1033 episodes identified after March 31, 1997. Measures:We adjusted for the higher probability of initial hospitalization in sicker residents using measures of illness severity and a hospitalization propensity score. The propensity score was derived from a logistic regression model that included patient, physician, and facility variables. Estimated costs were attributed to initial treatment setting. Results:After controlling for the probability of hospitalization and illness severity, hospitalization was not a significant mortality predictor (odds ratio 0.89, 95% confidence interval 0.52–1.52). Mean daily cost was
Journal of the American Geriatrics Society | 2004
Cynthia Herrick; Karen Steger-May; David R. Sinacore; Marybeth Brown; Kenneth B. Schechtman; Ellen F. Binder
138.24 for initial nursing home treatment and
Journal of the American Geriatrics Society | 2004
Steven Zweig; Robin L. Kruse; Ellen F. Binder; Kristina L. Szafara; David R. Mehr
419.75 for the hospital. Conclusions:After controlling for illness severity and propensity for hospitalization, hospital treatment is not associated with either increased or decreased risk for mortality for nursing home residents with LRIs. For residents with low and medium mortality risk, nursing home treatment is likely to be safe and less costly.
Journal of The National Comprehensive Cancer Network | 2017
Margaret A. Tempero; Mokenge P. Malafa; Mahmoud M. Al-Hawary; Horacio J. Asbun; Andrew Bain; Stephen W. Behrman; Al B. Benson; Ellen F. Binder; Dana Backlund Cardin; Charles Cha; E. Gabriela Chiorean; Vincent Chung; Brian G. Czito; Mary Dillhoff; Efrat Dotan; Cristina R. Ferrone; Jeffrey M. Hardacre; William G. Hawkins; Joseph M. Herman; Andrew H. Ko; Srinadh Komanduri; Albert C. Koong; Noelle K. LoConte; Andrew M. Lowy; Cassadie Moravek; Eric K. Nakakura; Eileen Mary O'Reilly; Jorge Obando; Sushanth Reddy; Courtney L. Scaife
Objectives: To identify factors associated with persistent hip pain in elderly hip fracture patients with physical frailty.
Annals of Internal Medicine | 2001
Ellen F. Binder; Daniel B. Williams; Kenneth B. Schechtman; Donna B. Jeffe; Wendy M. Kohrt
(See editorial comments by Dr. Joan Teno on pp 159–160)